Insulin Potentiation Therapy is a targeted treatment that complements the other elements of an integrative cancer treatment protocol. This therapy has been used since being developed in 1926 by Dr. Donato Perez Garcia in Mexico. Insulin is used to create an intentional state of hypoglycemia, or low blood sugar. This is done in a safe, controlled environment. Once hypoglycemia has been induced, standard chemotherapeutic agents are given intravenously. The insulin causes an increased uptake of chemotherapy agents by cancer cells. Since cancer cells are more responsive to insulin than are healthy cells, there is disproportionately greater uptake of the chemotherapy by cancer cells than by healthy cells. We can therefore use a lower dose of chemotherapy than we would normally.
Cancerous cells have been estimated to have six times as many insulin receptors as healthy cells, due to their higher demands for energy in the form of glucose. It is this disparity of receptors that IPT makes use of, to good effect. Since this allows us to use a much lower dose of chemo, severe side-effects, such as hair loss, vomiting, fatigue, and depression, can be averted.